Researchers at the University of Maryland Medical Center are developing a stem cell treatment that can be utilized to treat hypoplastic left heart syndrome (HLHS) in children. By taking a new approach to make the right side of the heart stronger instead of replacing the damaged left side, researchers hope to engender a more permanent fix. The procedure would represent a significant advancement over current HLHS treatments; which include heart transplants and reconstructive procedures that only provide temporary relief.
Building on earlier studies involving adults with heart disease, researchers have gained experience and knowledge as a result of the positive outcomes from stem cell treatments. These previous outcomes are promising for future stem cell treatments involving infants with HLHS, as researchers believe that a young heart should be more responsive.
This advancement in bioengineering will accelerate stem cell applications to treat a wider variety of heart-related conditions. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.